ASND
Ascendis Pharma A/S
Latest News for ASND
Morgan Stanley analyst Maxwell Skor maintained a Buy rating on Ascendis Pharma today and set a price target of $240.50. According to TipRanks, Skor......
An announcement from Ascendis Pharma ( ($ASND) ) is now available. On May 12, 2026, Ascendis Pharma A/S granted 31,250 new employee warrants, each ......
An announcement from Ascendis Pharma ( ($ASND) ) is now available. On May 12, 2026, Ascendis Pharma A/S granted 31,250 new employee warrants, each ......
Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Ascendis Pharma on May 8 and set a price target of $328.00. The company’s shar......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascendis Pharma (ASND) and Becton Dickinson (BDX) wi......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Prime Medicine, Inc. (PRME), Evolent Health (EVH) an......
Ascendis Pharma ( ($ASND) ) just unveiled an update. Ascendis Pharma A/S on May 7, 2026 filed a Form 6-K reporting unaudited condensed consolidated......
The latest announcement is out from Ascendis Pharma ( ($ASND) ). Ascendis Pharma reported first-quarter 2026 revenue of €247 million, driven largel......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascendis Pharma (ASND) and Rhythm Pharmaceuticals (R......
News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $237.47 | +0.9% | 295.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |